NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/15/2023
Back to search
Official data from USPTO
PROSTAPHANE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
08/15/2023
Trademark type
Word
Nice classes
5
Filing date
07/24/2020
Registration date
08/15/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2023
Last transaction
08/15/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2021-00-00
First use in commerce
2021-00-00
Drawing code
4
Owner type
99
Owner location
NOYAL-SUR-VILAINE, FR
Examiner
FREEMAN, BREANNA SHALEISE
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
OLGA
T. N. (pessoa física)
Representatives
Julianne Abelman Womble Bond Dickinson (US) LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
nutritional supplements for medical use for treating prostate cancer
Publications
History of USPTO decisions and trademark events.
35 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/15/2023
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/11/2023
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/11/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/06/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
02/01/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/08/2022
IUAF
USE AMENDMENT FILED
11/18/2022
EISU
TEAS STATEMENT OF USE RECEIVED
11/18/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/20/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/20/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/20/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/20/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/20/2022
EX2G
SOU EXTENSION 2 GRANTED
05/18/2022
EXT2
SOU EXTENSION 2 FILED
05/18/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/18/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/19/2021
EX1G
SOU EXTENSION 1 GRANTED
11/17/2021
EXT1
SOU EXTENSION 1 FILED
11/17/2021
EEXT
SOU TEAS EXTENSION RECEIVED
11/17/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/18/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/23/2021
PUBO
PUBLISHED FOR OPPOSITION
03/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/03/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/09/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/17/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/17/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/23/2020
GNRT
NON-FINAL ACTION E-MAILED
11/23/2020
CNRT
NON-FINAL ACTION WRITTEN
11/23/2020
DOCK
ASSIGNED TO EXAMINER
11/10/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/24/2020
NWAP
NEW APPLICATION ENTERED
07/28/2020
Continuous trademark protection
Get notified about every new filing that threatens PROSTAPHANE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.